Becky Bates

1.1k citations

16 papers · 664 indexed · h-index 10

Impact in

Critical Care and Intensive Care Medicine top 2%
- Nosocomial Infections in ICU
Applied Microbiology and Biotechnology top 5%
- Antibiotic Use and Resistance

Papers in ⓘ

Critical Care and Intensive Care Medicine 6
- Nosocomial Infections in ICU 3
Epidemiology 15
- Sepsis Diagnosis and Treatment 14
- Pneumonia and Respiratory Infections 3

Co-authors: Howard Levy (8 shared papers)Pierre‐François Laterre (6 shared papers)Richard G. Wunderink (2 shared papers)Sachin Yende (1 shared paper)David E. Joyce (1 shared paper)Rebecca L. Qualy (7 shared papers)Mark D. Williams (3 shared papers)Gary Garber (2 shared papers)
Journals: Critical Care Medicine (5 papers)Critical Care (2 papers)Surgical Infections (2 papers)CHEST Journal (2 papers)Clinical Infectious Diseases (1 paper)
Partner nations: United States Belgium South Africa

In The Last Decade

Becky Bates

15 papers receiving 633 citations

Peers

Countries citing papers authored by Becky Bates

Since Specialization

Citations

This map shows the geographic impact of Becky Bates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Becky Bates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Becky Bates more than expected).

Fields of papers citing papers by Becky Bates

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Becky Bates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Becky Bates. The network helps show where Becky Bates may publish in the future.

Co-authors

The 25 scholars most cited alongside Becky Bates, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Becky Bates Line = papers co-authored together Becky Bates links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Drotrecogin Alfa (activated) Improves In-hospital and 90-day Survival in Patients With Severe Sepsis and Community-acquired Pneumoni CHEST Journal ·Richard G. Wunderink, Sachin Yende, Pierre‐François Laterre, David E. Joyce, Becky Bates, Howard Levy	2003	182
2	Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study* Critical Care Medicine ·Pierre‐François Laterre, Gary Garber, Howard Levy, Richard G. Wunderink, Gary T. Kinasewitz, Jean-Pierre Sollet, Dennis G. Maki, Becky Bates, Sau Chi Betty Yan, Jean-François Dhainaut	2005	132
3	The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): Role, methodology, and results* Critical Care Medicine ·Jean-François Dhainaut, Pierre-François Laterre, Steven P. LaRosa, Howard Levy, Gary Garber, Darell Heiselman, Gary T. Kinasewitz, R. Bruce Light, Peter E. Morris, Roland M.H. Schein, Jean-Pierre Sollet, Becky Bates, Barbara G. Utterback, Dennis G. Maki	2003	69
4	CURB-65, PSI, and APACHE II to Assess Mortality Risk in Patients With Severe Sepsis and Community Acquired Pneumonia in PROWESS Journal of Intensive Care Medicine ·Guy A. Richards, Howard Levy, Pierre‐François Laterre, Charles Feldman, Brad Woodward, Becky Bates, Rebecca L. Qualy	2011	66
5	Benefit/risk profile of drotrecogin alfa (activated) in surgical patients with severe sepsis The American Journal of Surgery ·Philip S. Barie, Mark D. Williams, Jill Shwed McCollam, Becky Bates, Rebecca L. Qualy, Stephen F. Lowry, Donald E. Fry	2004	63
6	Drotrecogin Alfa (Activated) Treatment of Older Patients with Severe Sepsis Clinical Infectious Diseases ·E. Wesley Ely, Derek C. Angus, Mark D. Williams, Becky Bates, RL Qualy, Gordon R. Bernard	2003	61
7	Application of a population-based severity scoring system to individual patients results in frequent misclassification Critical Care ·Frank V. McL. Booth, Mary B. Short, Andrew F. Shorr, Nancy Arkins, Becky Bates, Rebecca L. Qualy, Howard Levy	2005	26
8	A retrospective observational study of drotrecogin alfa (activated) in adults with severe sepsis: Comparison with a controlled clinical trial* Critical Care Medicine ·Arthur P. Wheeler, Jay S. Steingrub, Gregory A. Schmidt, Philip Sanchez, Judith Jacobi, Walter T. Linde‐Zwirble, Becky Bates, Rebecca L. Qualy, Brad Woodward, Michael L. Zeckel	2008	25
9	Safety of Drotrecogin Alfa (Activated) in Surgical Patients with Severe Sepsis Surgical Infections ·Donald E. Fry, Gregory J. Beilman, Sara B. Johnson, Williams, George H. Rodman, Frank V. McL. Booth, Becky Bates, Jill Shwed McCollam, Stephen F. Lowry	2004	15
10	Steroid use in PROWESS severe sepsis patients treated with drotrecogin alfa (activated) Critical Care ·Howard Levy, Pierre‐François Laterre, Becky Bates, Rebecca L. Qualy	2005	14
11	Static and Dynamic Assessment of Biomarkers in Surgical Patients with Severe Sepsis Surgical Infections ·Stephen F. Lowry, Samir S. Awad, Henri R. Ford, William G. Cheadle, Mark D. Williams, Rebecca L. Qualy, Jill Shwed McCollam, Becky Bates, Donald E. Fry	2004	7
12	Steroid use in PROWESS severe sepsis patients treated with drotrecogin alfa (activated) Howard Levy, Pierre‐François Laterre, Becky Bates, RL Qualy	2005	1
13	CURB-65 PNEUMONIA SEVERITY INDEX AND APACHE II SCORES TO ASSESS MORTALITY RISK IN COMMUNITY-ACQUIRED PNEUMONIA PATIENTS FROM PROWESS CHEST Journal ·Guy A. Richards, Howard Levy, Pierre‐François Laterre, Charles Feldman, Becky Bates, Rebecca L. Qualy	2007	1
14	RESOURCE USE VARIATION AMONG SEVERE SEPSIS PATIENTS TREATED WITH DROTRECOGIN ALFA (ACTIVATED) IN THE XEUS STUDY Critical Care Medicine ·Walter T. Linde‐Zwirble, Frank R. Ernst, Becky Bates, Eli Lilly	2004	1
15	IMPROVED OUTCOMES IN CLOSED VERSUS OPEN MEDICAL ICUS AMONG SEVERE SEPSIS PATIENTS TREATED WITH DROTRECOGIN ALFA (ACTIVATED) Critical Care Medicine ·Jay S. Steingrub, Michael L. Cheatham, Karen Safcsak, Walter T. Linde‐Zwirble, Becky Bates, Frank R. Ernst, Mark B. Effron	2004	1
16	Enterprise-based HIV/AIDS strategies: Integration through organisational architecture South African Journal of Business Management ·Geongeun Lee, Robert Venter, Becky Bates	2004	0

About Becky Bates

Becky Bates is a scholar working on Critical Care and Intensive Care Medicine, Epidemiology, Endocrinology, Diabetes and Metabolism, Statistics and Probability and Anthropology, having authored 16 papers that have together received 664 indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (14 papers), Nosocomial Infections in ICU (3 papers), Hemodynamic Monitoring and Therapy (3 papers), Pneumonia and Respiratory Infections (3 papers), Heart Failure Treatment and Management (2 papers), Adrenal Hormones and Disorders (2 papers), Global and Cross-Cultural Management (1 paper) and HIV/AIDS Impact and Responses (1 paper). The work is most often cited by research in Critical Care and Intensive Care Medicine (210 citations), Applied Microbiology and Biotechnology (55 citations), Clinical Biochemistry (103 citations), Family Practice (33 citations) and Epidemiology (478 citations). Becky Bates has collaborated with scholars based in United States, Belgium and South Africa. Frequent co-authors include Howard Levy, Pierre‐François Laterre, Richard G. Wunderink, Sachin Yende, David E. Joyce, Rebecca L. Qualy, Mark D. Williams, Gary Garber, Gary T. Kinasewitz and Dennis G. Maki. Their work appears in journals such as Critical Care Medicine, Critical Care, Surgical Infections, CHEST Journal and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact